Wearlinq, maker of a wireless clinical-grade wearable 6-lead EKG, has secured a $14 million Series A investment and $5 million in venture debt funding. AIX Ventures led the Series A round, with ...
British horse racing has begun utilizing equine heart monitors in a select group of racing Thoroughbreds in an effort to provide new insight about exercise-associated sudden death (EASD), reports The ...
(Gray News) - The long-term use of melatonin could lead to heart failure, according to the American Heart Association. A study found that adults with insomnia who used melatonin for at least a year ...
Accumulating daily steps in longer bouts of walking is better for the heart than taking multiple short walks, a study shows — but it also found that small increases in walk duration can benefit ...
Tom Brownlee does not work for, consult, own shares in or receive funding from any company or organization that would benefit from this article, and has disclosed no relevant affiliations beyond their ...
During his regular checkup, a 9-year-old clouded leopard named Masala undergoes a procedure to get a tiny heart monitor implanted under his skin at the Smithsonian's Conservation Biology Institute in ...
To everyone’s surprise, Qualcomm has announced they have entered an agreement to acquire Arduino, the open-source hardware and software pioneer known for empowering millions of makers and developers ...
It ain’t over, is it? Just like the Guardians saving the best for the last part of the season, they did so in this game. It was the 10th inning. They had given up three runs to Texas, meaning it was 8 ...
A few weeks back, we reported on a research group that figured out how to measure heartrate using perturbations in WiFi signals. [Nick Bild] was interested in this so-called “Pulse-Fi” technique, but ...
Computer Science and Engineering Ph.D. student Nayan Bhatia demonstrates Pulse-Fi, technology that uses WiFi signals to measure a person's heart rate. Heart rate is one of the most basic and important ...
Novo Nordisk’s Wegovy cut the risk of heart attacks, stroke and death by more than Eli Lilly’s weight-loss drug Zepbound, a new study found.